U.S. Markets closed

Harmony Biosciences Holdings, Inc. (HRMY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.49-2.07 (-4.18%)
At close: 1:00PM EST

Harmony Biosciences Holdings, Inc.

630 West Germantown Pike
Suite 215
Plymouth Meeting, PA 19462
United States
484 539 9800

Full Time Employees150

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey S. AroninFounder & Non-Exec. ChairmanN/AN/A1968
Mr. John Charles Jacobs M.B.A.Pres, CEO & DirectorN/AN/A1967
Ms. Susan L. Drexler CPA, M.B.A.Chief Financial OfficerN/AN/A1969
Mr. David BradshawHead of Technical OperationsN/AN/AN/A
Ms. Sharon GoldbachHead of Facilities Operations & Exec. Admin.N/AN/AN/A
Ms. Lisa M. CaperelliHead of Investor RelationsN/AN/AN/A
Ms. Stephanie Wisdo J.D.Gen. Counsel & Compliance OfficerN/AN/AN/A
Ms. Nancy LeoneHead of Corp. CommunicationsN/AN/AN/A
Ms. Audrey MurphyHead of HRN/AN/AN/A
Dr. Jeffrey M. DaynoChief Medical OfficerN/AN/A1957
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.

Corporate Governance

Harmony Biosciences Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.